成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

ChemicalBook--->CAS DataBase List--->117423-74-2

117423-74-2

117423-74-2 Structure

117423-74-2 Structure
IdentificationBack Directory
[Name]

LY 223982
[CAS]

117423-74-2
[Synonyms]

CGS23131
LY 223982
SKF107324)
LY223982 Exclusive
SYZSSLLFRVDRHL-QPJJXVBHSA-N
LY223982 (Synonyms: CGS23131
5-(3-Carboxybenzoyl)-2-[(E)-6-(4-methoxyphenyl)-5-hexenyloxy]benzenepropanoic acid
Benzenepropanoic acid, 5-(3-carboxybenzoyl)-2-[[(5E)-6-(4-methoxyphenyl)-5-hexen-1-yl]oxy]-
[Molecular Formula]

C30H30O7
[MDL Number]

MFCD00876442
[MOL File]

117423-74-2.mol
[Molecular Weight]

502.55
Chemical PropertiesBack Directory
[Melting point ]

151-152 °C
[Boiling point ]

753.8±60.0 °C(Predicted)
[density ]

1.235±0.06 g/cm3(Predicted)
[storage temp. ]

-20°C Freezer
[solubility ]

Chloroform (Slightly, Heated, Sonicated), DMSO (Very Slightly)
[form ]

A crystalline solid
[pka]

3.81±0.10(Predicted)
[color ]

White to off-white
Hazard InformationBack Directory
[Description]

Leukotriene B4 (LTB4) is a dihydroxy fatty acid derived from the 5-lipoxygenase pathway of arachidonic acid metabolism and is an important mediator of the inflammatory process. The benzophenone dicarboxylic acid derivative LY223982 is a potent BLT1 receptor antagonist. It inhibits the specific binding of radiolabeled-LTB4 to isolated human neutrophils with an IC50 value of 13.2 nM. LY223982 inhibits the leukotriene B4 (LTB4)-induced aggregation of guinea pig and human neutrophils with IC50 values of 74 and 100 nM, respectively. However, concentrations of LY223982 up to 10 μM do not inhibit binding of LTB4 to human BLT1 or BLT2 expressed in CHO cells.
[Uses]

LY223982 is a potent P2Y7 (BLT1) receptor antagonist.
[storage]

Store at -20°C
117423-74-2 suppliers list
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354 +1-00000000000 , +1-00000000000
Website: https://www.targetmol.com/
Company Name: Aladdin Scientific
Tel:
Website: www.aladdinsci.com/
Company Name: TargetMol Chemicals Inc.
Tel: +8613564774135 , +8613564774135
Website:
Company Name: ShangHai Caerulum Pharma Discovery Co., Ltd.  
Tel: 18149758185 18149758185
Website: www.caerulumpharma.com
Company Name: Shanghai EFE Biological Technology Co., Ltd.  
Tel: 021-65675885 18964387627
Website: http://www.efebio.com
Company Name: Angel Pharmatech, Ltd.  
Tel: 17317130613
Website: http://www.angelpharmatech.com
Company Name: Fan De(Beijing) Biotechnology Co., Ltd.  
Tel: 15911056312
Website: www.bio-fount.com
Company Name: DC Chemicals  
Tel: 021-58447131 13564518121
Website: http://www.is0513.com/ShowSupplierProductsList927327/0.htm
Company Name: ChemeGen(Shanghai) Biotechnology Co.,Ltd.  
Tel: 18818260767
Website: http://www.chemegen.com
Company Name: Changzhou Bojia Biomedical Technology Co., Ltd.  
Tel: 2122619822
Website: www.is0513.com/showsupplierproductslist849747/0.htm
Company Name: TargetMol Chemicals Inc.  
Tel: 4008200310
Website: https://www.targetmol.cn/
Company Name: Cayman Chemical Company  
Tel: (800)364-9897
Website: www.caymanchem.com
Company Name: ApexBio Technology  
Tel: + 1-832-696-8203
Website: www.apexbt.com
Company Name: United States Biological  
Tel: 1-800-520-3011
Website: www.usbio.net
Company Name: Neobioscience Co., Ltd.  
Tel: 4006-800-892
Website: www.nbs-bio.com
Company Name: Absin Bioscience Inc.  
Tel: 021-38015121-8802
Website: http://www.absin.cn
Company Name: Cayman Chemical Company  
Tel: (800) 364-9897
Website: www.caymanchem.com
Company Name: United States Biological  
Tel: 800.520.3011 or 781.639.5092
Website: www.usbio.net
Tags:117423-74-2 Related Product Information
6342-77-4

This site uses cookies
This website uses cookies and similar technologies to store and retrieve information about your use of this website. This information helps us to provide, analyse and improve our services, which may include personalised content or advertising. We may share this information with Google and other third parties. This cookies are necessary for our website to work properly . By clicking "Continue" or continuing to browse our site you are agreeing to our and our partners use of cookies.
Accept